Cell Therapeutics

runway takeoff airport cleared go
Biotech

'Unprecedented' data prime Kyverna for 1st autoimmune CAR-T drug

Kyverna's CD19 CAR-T showed “unprecedented” results doctors have never seen with existing off-label therapies, the lead study investigator said.
Angus Liu Dec 15, 2025 10:55am
Legend
Favicon Fierce Pharma

J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T

Nov 12, 2025 11:36am
Warren Biddle

JPM25: Kyverna CEO sets priorities for CAR-T autoimmune biotech

Jan 13, 2025 7:30am